Silicon Republic December 6, 2024
The funds will be used to drive the development of its innovative product, which aims to increase the safety of C-section surgery.
Maternal health start-up Nua Surgical announced today (6 December) that it has secured €6.5m in Series A funding to develop and commercialise its SteriCision C-section retractor.
The Galway-based business’ device gives obstetricians hands-free, unobstructed access to the uterus during C-section surgery, which, the company said, reduces the risk of wound trauma and facilitates safer procedures.
Using the funds, the medtech company will drive the manufacturing, testing, regulatory clearance and early commercialisation of its product. This involves expanding the team, establishing manufacturing in Ireland and meeting the regulatory requirements necessary to gain FDA clearance.
According to Nua Surgical, the...
Today's Sponsors
Today's Sponsor